References
  1. WHO. Coronavirus disease (COVID-2019) situation reports. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Access on December 27, 2020.
  2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062
  3. Ayten O, Saylan B. Retrospective analysis of severe COVID-19 pneumonia patients treated with lopinavir/ritonavir: A comparison with survivor and non-survivor patients. Southern African Journal of Infectious Diseases;2020; 35: 2312-0053 DOI: https://doi.org/10.4102/sajid.v35i1.233
  4. Saklayen M.G, The Global Epidemic of the Metabolic Syndrome . Review Curr Hypertens Rep . 2018 Feb 26;20(2):12.
  5. Hoffman E.L, Von Wald T, Hansen K. The metabolic syndrome . South Dakota Medicine. 2015; Spec No:24-8.
  6. Rottoli M, Bernante P, Belvedere A, et al. Obesity is one of the strongest risk factor for respiratory failure and death in COVID-19. Patients: A Retrospective Multicentric Cohort Study, 2020
  7. Grundy S.M, Cleeman J.I, Daniels S.R, Eckel R.H, Franklin B.A, Gordon D.J et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-52.
  8. COVID-19 (SARS-CoV-2 Infection) Guide of Ministry of Health of Republic of Turkey, April 14, 2020
  9. Chang Y, Yu C, Chang S, Galvin JR, Liu H, Hsiao C, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Radiology 2005;236(3):1067–75
  10. Norman, G. (2010). Likert scales, levels of measurement and the “laws” of statistics. Advances in Health Sciences Education, 15 (5), 625-632
  11. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242.
  12. Xie J, Zu Y, Alkhatib A, Pham T.T, Gill F, Jang A et al. Metabolic Syndrome and COVID-19 Mortality Among Adult Black Patients in New Orleans. Diabetes Care. 2020 Aug 25;44(1):188-193.
  13. Lohia P, Kapur S, Benjaram S, Pandey A, Mir T, Seyoum B. Metabolic Syndrome and clinical outcomes in patients infected with COVID19: Does age, sex and race of the patient with Metabolic Syndrome matter? J Diabetes. 2021 Jan 16. doi: 10.1111/1753-0407.13157. Online ahead of print.
  14. Rubel A.A, Chong P.L, Abdullah M.S, Asli R, Momin R.N, Mani B.I et al. Lipemic serum in patients with Coronavirus Disease 2019 (COVID‐19) undergoing treatment. J Med Virol. 2020 Jun 2 : 10.1002/ jmv. 25942. doi: 10.1002/jmv.25942 [Epub ahead of print]
  15. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F et al. The metabolic syndrome, incidence of diabetes and mortality among the elderly: The Italian Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci. 2006 May;61(5):505-10
  16. Hildrum B, Mykletun A, Dahl AA, Midthjell K. Metabolic syndrome and risk of mortality in middle-aged versus elderly individuals: the Nord-Trøndelag Health Study (HUNT). Diabetologia . 2009 Apr;52(4):583-90.
  17. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020 Jul;146(1):110-118.
  18. Albitar O, Ballouze R, Ooi J.P, Ghadzi S.M.S. Risk factors for mortality among COVID-19 patients. Diabetes Res Clin Pract. 2020 Aug;166:108293.
  19. Wartz H, Waschki B, Kirsten A, Müller C, Kretschmar G, Meyer T at al . The Metabolic Syndrome in Patients With Chronic Bronchitis and COPD: Frequency and Associated Consequences for Systemic Inflammation and Physical Inactivity. Chest. 2009 October: 136; 4;1039-1046
  20. Clini E, Crisafulli E, Radaeli A, Malerba M. COPD and the metabolic syndrome: an intriguing association Internal and Emergency Medicine 2013:8;283–289
  21. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985.
  22. Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. COVID-19 Lombardy ICU Network. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180:1345–1355.
  23. Singh AK, Gillies CL, Singh R, Singh A, Chudasama Y, Coles B, et al. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis Diabetes Obes Metab 2020 Jun 23 : 10.1111/dom.14124. doi: 10.1111/dom.14124 [Epub ahead of print]
  24. Nakajima K. Serious Conditions in COVID-19 Accompanied With a Feature of Metabolic Syndrome. J Clin Med Res. 2020 May; 12(5): 273–275.Leisegang K, Henkel R, Agarwal A. Obesity and metabolic syndrome associated with systemic inflammation and the impact on the male reproductive system. Am J Reprod Immunol. 2019;82(5):e13178
  25. Chocair P.R, Neves P.D.M.M, Pereira L.V.B, Mohrbacher S, Oliveira E.S, Nardotto L.L et al. Covid-19 and Metabolic Syndrome . Letters to editor. Rev Assoc Med Bras. 2020; 66(7):871-875